DEUTERIERTES ETRAVIRIN

European patent · EP2212298 · Deleted

Register entry

Publication number
EP2212298
Application number
EP08839230
Kind
European patent with effect for Switzerland and Liechtenstein
Status
Deleted
Specification
Granted
Filed
Oct 17, 2008
Published
Aug 4, 2010
Granted
Mar 27, 2013
Deleted
Oct 31, 2015
Reason
Annual fee unpaid
IPC classes
C07D 239/48 (2006.01)
A61K 31/505 (2006.01)
A61P 31/18 (2006.01)
Priority
US 980869 P 18.10.2007
PCT application
PCT/US2008/011856 17.10.2008
PCT publication
WO2009/051782 23.04.2009
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. May 18, 2016

    Deleted, fee unpaid

    Published in Swissreg on 18.05.2016

  2. Jan 14, 2014

    Agent entered

    Representative
    Marks & Clerk (Luxembourg) LLP, Dreikönigstrasse 31a, 8002 Zürich

    Published in Swissreg on 14.01.2014

  3. Mar 27, 2013

    Granted

    Published in Swissreg on 27.03.2013

Parties

Holder

Concert Pharmaceuticals, Inc.

Concert Pharmaceuticals Inc.

99 Hayden Avenue, Suite 100, Lexington, MA 02421-7966, US

Agent

Marks & Clerk (Luxembourg) LLP

Dreikönigstrasse 31a, 8002 Zürich

Inventor

MASSE, Craig E.

Cambridge Massachusetts 02139, US

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.